Available for Prime members, the move is sure to have significant reverberations in the healthcare industry.
For biosimilars, the average sales price has decreased at a negative compound annual growth rate of -9% to -24%.
While the average brand name copay is more than $56, the average generic copay is just around $6.
The impact of three generic rivals on its fish-oil derived heart pill prompted the latest cost-cutting move.
California to attempt to develop generic drugs; Recovered COVID-19 patients in South Korea experienced side effects; Children make up 10% of coronavirus cases in the U.S.
Celgene’s drug will now have time to establish itself in the market without generic competition.
The website is part of Teva’s rebranding efforts, which began in March.
Alok Sonig, chief executive officer of developed markets at Dr. Reddy’s Laboratories, articulates the benefits of generics.
The pharmaceutical company is undergoing a global restructuring as it relaunches its brand in the U.S. and Canada.
FDA issues new policies for compounded drugs; U.S. doctors test CRISPR on cancer patients for the first time; Palio merged into GSW
Get the most out of
Register for free and enjoy unlimited access to: